By Marabou Marabou and Perlara Partner to Fund Research for Curing Rare Genetic Diseases, Aiming to Save Lives and Pave the Way for Longevity Studies
|
 | By Corporate Ads Substantial Funding Agreements, Debt Resolution and Successful Clinical Trial Progress Towards Accelerated Drug Approval
|
 | By Corporate Ads Genprex Stock Symbol: GNPX is Gene Therapy Focused on Life-Changing Developments for Cancer and Diabetes
|
| By Corporate Ads NRXP: Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics.
|
| By Corporate Ads Working With World-Class Institutions/Collaborators to Provide Novel Treatment Approaches. Stock Symbol: GNPX
|
By ARPA-H Investor Catalyst Hub Phronetik Joins a Nationwide Network Working to Accelerate Transformative Health Solutions
|
By Creative Biolabs Creative Biolabs introduces innovative solutions for live biotherapeutics to empower scientists and pharmaceutical companies in their quest for groundbreaking therapies against gut diseases.
|
By OLAB Bioscience OLAB Bioscience, a global leader in industrial biotechnology specializing in algorithmic and AI-based solutions for synthetic biology, and CJ BIO, a prominent name in the bioproducts industry and business unit of South Korea-based CJ CheilJedang, are...
|
By IVIEW Therapeutics Inc. IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.
|
By Biorex Food Diagnostics Biorex Food Diagnostics announced today, the launch of its cutting-edge FlowSense product line, with the first phase designed specifically for the honey industry.
|
By Tiamat Sciences Corporation Quantoom Biosciences and Tiamat Sciences Announce Strategic Partnership to Revolutionize mRNA Production Quantoom Biosciences S.A.
|
 | By Genesis AEC Genesis AEC, a leading designer and builder of facilities for the pharmaceutical and biotech industries, is proud to announce it has received the Gold Safety Award from Highwire, the Contractor Success platform for builders and owners of capital...
|
By Manhattan BioSolutions, Inc. Manhattan BioSolutions, Inc. ("Manhattan Bio"), an emerging biotechnology company developing new classes of precision biologics for the treatment of advanced cancers, today announced a collaborative poster presentation at the American Association for...
|
By Mainstay Engineering Group, Inc. Mainstay Engineering Group, Inc. (Megr.com), a leading structural and civil engineering services company, has been ranked one of the Largest Engineering Firms in Greater Philadelphia, by The Philadelphia Business Journal.
|
By alpha lifetech Antibody phage display technology has revolutionized the field of immunovirology with its application in viral disease diagnostics and antiviral therapy.
|
By Creative Biolabs With the spotlight on mRNA vaccines post the prestigious Nobel Prize in Physiology or Medicine 2023, Creative Biolabs stands poised to revolutionize this groundbreaking technology.
|
By ALPHA LIFETECH INC. Alpha Lifetech Inc. has developed and commercialized an integrated service covering native or synthesized library construction and screening, generation of specific monoclonal antibodies
|
By ALPHA LIFETECH INC. Proteins, the molecular workhorses of life, hold the keys to understanding complex biological processes. To explore and analyze proteins in detail, scientists rely on a range of protein purification methods.
|
By Micregen Ltd Micregen, a pioneering biotech company committed to increasing health span and prolonging the period of high-quality active life, is proud to announce that at the 2023 UK Pharma Industry Awards its Secretomix® Platform has won Innovation of the Year.
|
By KML Vision GmbH KML Vision GmbH, a bioimage analysis software provider, and Phoenestra GmbH, specializing in stem cell bioprocessing, have initiated a collaborative venture.
|
By Creative Biolabs Creative Biolabs updated its NAA solution, which was designed to provide invaluable insights into autoimmune diseases and autoantibody profiling and promises to propel the field of
|
By Neuronity Therapeutics, Inc. Neuronity Therapeutics, Inc., a pioneering biotech company focused on neurodegenerative diseases, is delighted to announce the receipt of a $780k grant in collaboration with the University of Georgia (UGA) from The Michael J. Fox Foundation (MJFF).
|
 | By We Decode We Decode is proud to announce that our "We Decode DNA Kit" has been named one of the top 50 most innovative products of 2023 by Innovation & Tech Today (I&TT)
|
By Galaxy Genomics Corp. Offers Advanced Mathematical and Computational Algorithms for Global Industry Use
|
By PTS Diagnostics Key strategic alliance for both companies as they work to close gaps in care for patients with chronic disease around the world.
|
By Creative Biolabs Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery.
|
By Phoreus Biotech The new product offers a superior alternative to industry-leading, lipid-based reagents
|
 | By Mary Jane's People The new website design includes The Work Bench, the company's new training and development tool for professional and personal growth.
|
By Creative Biolabs A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.
|
By KML Vision GmbH Bioimage analysis software provider KML Vision GmbH and MedTech company PreciPoint GmbH have embarked upon a joint collaboration initiative.
|
By Ysios Capital Partners Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 and Salvatore Scaffidi, who joined the Ysios Fellowship program in 2020, has been promoted to Associate.
|
